Turk Ilac Ve Serum Sanayi Anonim Sirketi reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TRY 1,913.26 million compared to TRY 1,636.91 million a year ago. Net income was TRY 105.72 million compared to net loss of TRY 81.65 million a year ago.

Basic earnings per share from continuing operations was TRY 0.653 compared to basic loss per share from continuing operations of TRY 0.505 a year ago.